The global market for Beta Actin Antibody was valued at US$ 12.00 million in the year 2024 and is projected to reach a revised size of US$ 27.63 million by 2031, growing at a CAGR of 12.0% during the forecast period.

Beta Actin Antibody Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Beta Actin Antibody competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Beta-actin antibodies are monoclonal or polyclonal antibodies used to detect β-actin and are widely used in Western blot, immunofluorescence, and immunohistochemistry experiments. β-Actin is a crucial component of the cytoskeleton, stably expressed and widely present in various cells and tissues. It is often used as a loading control for quantitative protein expression analysis and experimental standardization. This antibody plays a critical role in the accuracy and reproducibility of experimental results.Sales volume in 2024 is expected to be 125,000 units, with an average price of US$95 per unit.Most of them are based on customized production, with a single-line production capacity of more than 20,000.

North American market for Beta Actin Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Beta Actin Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Beta Actin Antibody include Thermo Fisher Scientific, Promega Corporation, New England Biolabs, Roche, QIAGEN GmbH, Merck, Bio-Rad Laboratories, Aladdin, TIANGEN Biotech, Amyjet Scientific, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Beta Actin Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta Actin Antibody.

The Beta Actin Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Beta Actin Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Beta Actin Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Beta Actin Antibody Market Report

Report Metric	Details
Report Name	Beta Actin Antibody Market
Accounted market size in year	US$ 12.00 million
Forecasted market size in 2031	US$ 27.63 million
CAGR	12.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	2KU 10KU 20KU 100KU Others
Segment by Application	Biopharmaceutical Laboratories University Laboratories Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Thermo Fisher Scientific, Promega Corporation, New England Biolabs, Roche, QIAGEN GmbH, Merck, Bio-Rad Laboratories, Aladdin, TIANGEN Biotech, Amyjet Scientific, Vazyme Biotech, Bioer Technology, Yeasen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Beta Actin Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Beta Actin Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Beta Actin Antibody Market growing?

Ans: The Beta Actin Antibody Market witnessing a CAGR of 12.0% during the forecast period 2025-2031.

What is the Beta Actin Antibody Market size in 2031?

Ans: The Beta Actin Antibody Market size in 2031 will be US$ 27.63 million.

Who are the main players in the Beta Actin Antibody Market report?

Ans: The main players in the Beta Actin Antibody Market are Thermo Fisher Scientific, Promega Corporation, New England Biolabs, Roche, QIAGEN GmbH, Merck, Bio-Rad Laboratories, Aladdin, TIANGEN Biotech, Amyjet Scientific, Vazyme Biotech, Bioer Technology, Yeasen

What are the Application segmentation covered in the Beta Actin Antibody Market report?

Ans: The Applications covered in the Beta Actin Antibody Market report are Biopharmaceutical Laboratories, University Laboratories, Others

What are the Type segmentation covered in the Beta Actin Antibody Market report?

Ans: The Types covered in the Beta Actin Antibody Market report are 2KU, 10KU, 20KU, 100KU, Others

1 Beta Actin Antibody Market Overview

1.1 Product Definition

1.2 Beta Actin Antibody by Type

1.2.1 Global Beta Actin Antibody Market Value Comparison by Type (2024 VS 2031)

1.2.2 2KU

1.2.3 10KU

1.2.4 20KU

1.2.5 100KU

1.2.6 Others

1.3 Beta Actin Antibody by Application

1.3.1 Global Beta Actin Antibody Market Value by Application (2024 VS 2031)

1.3.2 Biopharmaceutical Laboratories

1.3.3 University Laboratories

1.3.4 Others

1.4 Global Beta Actin Antibody Market Size Estimates and Forecasts

1.4.1 Global Beta Actin Antibody Revenue 2020-2031

1.4.2 Global Beta Actin Antibody Sales 2020-2031

1.4.3 Global Beta Actin Antibody Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Beta Actin Antibody Market Competition by Manufacturers

2.1 Global Beta Actin Antibody Sales Market Share by Manufacturers (2020-2025)

2.2 Global Beta Actin Antibody Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Beta Actin Antibody Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Beta Actin Antibody, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Beta Actin Antibody, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Beta Actin Antibody, Product Type & Application

2.7 Global Key Manufacturers of Beta Actin Antibody, Date of Enter into This Industry

2.8 Global Beta Actin Antibody Market Competitive Situation and Trends

2.8.1 Global Beta Actin Antibody Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Beta Actin Antibody Players Market Share by Revenue

2.8.3 Global Beta Actin Antibody Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Beta Actin Antibody Market Scenario by Region

3.1 Global Beta Actin Antibody Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Beta Actin Antibody Sales by Region: 2020-2031

3.2.1 Global Beta Actin Antibody Sales by Region: 2020-2025

3.2.2 Global Beta Actin Antibody Sales by Region: 2026-2031

3.3 Global Beta Actin Antibody Revenue by Region: 2020-2031

3.3.1 Global Beta Actin Antibody Revenue by Region: 2020-2025

3.3.2 Global Beta Actin Antibody Revenue by Region: 2026-2031

3.4 North America Beta Actin Antibody Market Facts & Figures by Country

3.4.1 North America Beta Actin Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Beta Actin Antibody Sales by Country (2020-2031)

3.4.3 North America Beta Actin Antibody Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Beta Actin Antibody Market Facts & Figures by Country

3.5.1 Europe Beta Actin Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Beta Actin Antibody Sales by Country (2020-2031)

3.5.3 Europe Beta Actin Antibody Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Beta Actin Antibody Market Facts & Figures by Region

3.6.1 Asia Pacific Beta Actin Antibody Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Beta Actin Antibody Sales by Region (2020-2031)

3.6.3 Asia Pacific Beta Actin Antibody Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Beta Actin Antibody Market Facts & Figures by Country

3.7.1 Latin America Beta Actin Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Beta Actin Antibody Sales by Country (2020-2031)

3.7.3 Latin America Beta Actin Antibody Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Beta Actin Antibody Market Facts & Figures by Country

3.8.1 Middle East and Africa Beta Actin Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Beta Actin Antibody Sales by Country (2020-2031)

3.8.3 Middle East and Africa Beta Actin Antibody Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Beta Actin Antibody Sales by Type (2020-2031)

4.1.1 Global Beta Actin Antibody Sales by Type (2020-2025)

4.1.2 Global Beta Actin Antibody Sales by Type (2026-2031)

4.1.3 Global Beta Actin Antibody Sales Market Share by Type (2020-2031)

4.2 Global Beta Actin Antibody Revenue by Type (2020-2031)

4.2.1 Global Beta Actin Antibody Revenue by Type (2020-2025)

4.2.2 Global Beta Actin Antibody Revenue by Type (2026-2031)

4.2.3 Global Beta Actin Antibody Revenue Market Share by Type (2020-2031)

4.3 Global Beta Actin Antibody Price by Type (2020-2031)

5 Segment by Application

5.1 Global Beta Actin Antibody Sales by Application (2020-2031)

5.1.1 Global Beta Actin Antibody Sales by Application (2020-2025)

5.1.2 Global Beta Actin Antibody Sales by Application (2026-2031)

5.1.3 Global Beta Actin Antibody Sales Market Share by Application (2020-2031)

5.2 Global Beta Actin Antibody Revenue by Application (2020-2031)

5.2.1 Global Beta Actin Antibody Revenue by Application (2020-2025)

5.2.2 Global Beta Actin Antibody Revenue by Application (2026-2031)

5.2.3 Global Beta Actin Antibody Revenue Market Share by Application (2020-2031)

5.3 Global Beta Actin Antibody Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Thermo Fisher Scientific

6.1.1 Thermo Fisher Scientific Company Information

6.1.2 Thermo Fisher Scientific Description and Business Overview

6.1.3 Thermo Fisher Scientific Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Thermo Fisher Scientific Beta Actin Antibody Product Portfolio

6.1.5 Thermo Fisher Scientific Recent Developments/Updates

6.2 Promega Corporation

6.2.1 Promega Corporation Company Information

6.2.2 Promega Corporation Description and Business Overview

6.2.3 Promega Corporation Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Promega Corporation Beta Actin Antibody Product Portfolio

6.2.5 Promega Corporation Recent Developments/Updates

6.3 New England Biolabs

6.3.1 New England Biolabs Company Information

6.3.2 New England Biolabs Description and Business Overview

6.3.3 New England Biolabs Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.3.4 New England Biolabs Beta Actin Antibody Product Portfolio

6.3.5 New England Biolabs Recent Developments/Updates

6.4 Roche

6.4.1 Roche Company Information

6.4.2 Roche Description and Business Overview

6.4.3 Roche Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Roche Beta Actin Antibody Product Portfolio

6.4.5 Roche Recent Developments/Updates

6.5 QIAGEN GmbH

6.5.1 QIAGEN GmbH Company Information

6.5.2 QIAGEN GmbH Description and Business Overview

6.5.3 QIAGEN GmbH Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.5.4 QIAGEN GmbH Beta Actin Antibody Product Portfolio

6.5.5 QIAGEN GmbH Recent Developments/Updates

6.6 Merck

6.6.1 Merck Company Information

6.6.2 Merck Description and Business Overview

6.6.3 Merck Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Merck Beta Actin Antibody Product Portfolio

6.6.5 Merck Recent Developments/Updates

6.7 Bio-Rad Laboratories

6.7.1 Bio-Rad Laboratories Company Information

6.7.2 Bio-Rad Laboratories Description and Business Overview

6.7.3 Bio-Rad Laboratories Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Bio-Rad Laboratories Beta Actin Antibody Product Portfolio

6.7.5 Bio-Rad Laboratories Recent Developments/Updates

6.8 Aladdin

6.8.1 Aladdin Company Information

6.8.2 Aladdin Description and Business Overview

6.8.3 Aladdin Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Aladdin Beta Actin Antibody Product Portfolio

6.8.5 Aladdin Recent Developments/Updates

6.9 TIANGEN Biotech

6.9.1 TIANGEN Biotech Company Information

6.9.2 TIANGEN Biotech Description and Business Overview

6.9.3 TIANGEN Biotech Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.9.4 TIANGEN Biotech Beta Actin Antibody Product Portfolio

6.9.5 TIANGEN Biotech Recent Developments/Updates

6.10 Amyjet Scientific

6.10.1 Amyjet Scientific Company Information

6.10.2 Amyjet Scientific Description and Business Overview

6.10.3 Amyjet Scientific Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Amyjet Scientific Beta Actin Antibody Product Portfolio

6.10.5 Amyjet Scientific Recent Developments/Updates

6.11 Vazyme Biotech

6.11.1 Vazyme Biotech Company Information

6.11.2 Vazyme Biotech Description and Business Overview

6.11.3 Vazyme Biotech Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Vazyme Biotech Beta Actin Antibody Product Portfolio

6.11.5 Vazyme Biotech Recent Developments/Updates

6.12 Bioer Technology

6.12.1 Bioer Technology Company Information

6.12.2 Bioer Technology Description and Business Overview

6.12.3 Bioer Technology Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Bioer Technology Beta Actin Antibody Product Portfolio

6.12.5 Bioer Technology Recent Developments/Updates

6.13 Yeasen

6.13.1 Yeasen Company Information

6.13.2 Yeasen Description and Business Overview

6.13.3 Yeasen Beta Actin Antibody Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Yeasen Beta Actin Antibody Product Portfolio

6.13.5 Yeasen Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Beta Actin Antibody Industry Chain Analysis

7.2 Beta Actin Antibody Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Beta Actin Antibody Production Mode & Process Analysis

7.4 Beta Actin Antibody Sales and Marketing

7.4.1 Beta Actin Antibody Sales Channels

7.4.2 Beta Actin Antibody Distributors

7.5 Beta Actin Antibody Customer Analysis

8 Beta Actin Antibody Market Dynamics

8.1 Beta Actin Antibody Industry Trends

8.2 Beta Actin Antibody Market Drivers

8.3 Beta Actin Antibody Market Challenges

8.4 Beta Actin Antibody Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

List of Tables

Table 1. Global Beta Actin Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Beta Actin Antibody Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Beta Actin Antibody Market Competitive Situation by Manufacturers in 2024

Table 4. Global Beta Actin Antibody Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Beta Actin Antibody Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Beta Actin Antibody Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Beta Actin Antibody Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Beta Actin Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Beta Actin Antibody, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Beta Actin Antibody, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Beta Actin Antibody, Product Type & Application

Table 12. Global Key Manufacturers of Beta Actin Antibody, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Beta Actin Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta Actin Antibody as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Beta Actin Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Beta Actin Antibody Sales by Region (2020-2025) & (K Units)

Table 18. Global Beta Actin Antibody Sales Market Share by Region (2020-2025)

Table 19. Global Beta Actin Antibody Sales by Region (2026-2031) & (K Units)

Table 20. Global Beta Actin Antibody Sales Market Share by Region (2026-2031)

Table 21. Global Beta Actin Antibody Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Beta Actin Antibody Revenue Market Share by Region (2020-2025)

Table 23. Global Beta Actin Antibody Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Beta Actin Antibody Revenue Market Share by Region (2026-2031)

Table 25. North America Beta Actin Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Beta Actin Antibody Sales by Country (2020-2025) & (K Units)

Table 27. North America Beta Actin Antibody Sales by Country (2026-2031) & (K Units)

Table 28. North America Beta Actin Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Beta Actin Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Beta Actin Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Beta Actin Antibody Sales by Country (2020-2025) & (K Units)

Table 32. Europe Beta Actin Antibody Sales by Country (2026-2031) & (K Units)

Table 33. Europe Beta Actin Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Beta Actin Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Beta Actin Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Beta Actin Antibody Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Beta Actin Antibody Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Beta Actin Antibody Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Beta Actin Antibody Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Beta Actin Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Beta Actin Antibody Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Beta Actin Antibody Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Beta Actin Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Beta Actin Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Beta Actin Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Beta Actin Antibody Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Beta Actin Antibody Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Beta Actin Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Beta Actin Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Beta Actin Antibody Sales (K Units) by Type (2020-2025)

Table 51. Global Beta Actin Antibody Sales (K Units) by Type (2026-2031)

Table 52. Global Beta Actin Antibody Sales Market Share by Type (2020-2025)

Table 53. Global Beta Actin Antibody Sales Market Share by Type (2026-2031)

Table 54. Global Beta Actin Antibody Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Beta Actin Antibody Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Beta Actin Antibody Revenue Market Share by Type (2020-2025)

Table 57. Global Beta Actin Antibody Revenue Market Share by Type (2026-2031)

Table 58. Global Beta Actin Antibody Price (US$/Unit) by Type (2020-2025)

Table 59. Global Beta Actin Antibody Price (US$/Unit) by Type (2026-2031)

Table 60. Global Beta Actin Antibody Sales (K Units) by Application (2020-2025)

Table 61. Global Beta Actin Antibody Sales (K Units) by Application (2026-2031)

Table 62. Global Beta Actin Antibody Sales Market Share by Application (2020-2025)

Table 63. Global Beta Actin Antibody Sales Market Share by Application (2026-2031)

Table 64. Global Beta Actin Antibody Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Beta Actin Antibody Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Beta Actin Antibody Revenue Market Share by Application (2020-2025)

Table 67. Global Beta Actin Antibody Revenue Market Share by Application (2026-2031)

Table 68. Global Beta Actin Antibody Price (US$/Unit) by Application (2020-2025)

Table 69. Global Beta Actin Antibody Price (US$/Unit) by Application (2026-2031)

Table 70. Thermo Fisher Scientific Company Information

Table 71. Thermo Fisher Scientific Description and Business Overview

Table 72. Thermo Fisher Scientific Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Thermo Fisher Scientific Beta Actin Antibody Product

Table 74. Thermo Fisher Scientific Recent Developments/Updates

Table 75. Promega Corporation Company Information

Table 76. Promega Corporation Description and Business Overview

Table 77. Promega Corporation Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Promega Corporation Beta Actin Antibody Product

Table 79. Promega Corporation Recent Developments/Updates

Table 80. New England Biolabs Company Information

Table 81. New England Biolabs Description and Business Overview

Table 82. New England Biolabs Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. New England Biolabs Beta Actin Antibody Product

Table 84. New England Biolabs Recent Developments/Updates

Table 85. Roche Company Information

Table 86. Roche Description and Business Overview

Table 87. Roche Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Roche Beta Actin Antibody Product

Table 89. Roche Recent Developments/Updates

Table 90. QIAGEN GmbH Company Information

Table 91. QIAGEN GmbH Description and Business Overview

Table 92. QIAGEN GmbH Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. QIAGEN GmbH Beta Actin Antibody Product

Table 94. QIAGEN GmbH Recent Developments/Updates

Table 95. Merck Company Information

Table 96. Merck Description and Business Overview

Table 97. Merck Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Merck Beta Actin Antibody Product

Table 99. Merck Recent Developments/Updates

Table 100. Bio-Rad Laboratories Company Information

Table 101. Bio-Rad Laboratories Description and Business Overview

Table 102. Bio-Rad Laboratories Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Bio-Rad Laboratories Beta Actin Antibody Product

Table 104. Bio-Rad Laboratories Recent Developments/Updates

Table 105. Aladdin Company Information

Table 106. Aladdin Description and Business Overview

Table 107. Aladdin Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Aladdin Beta Actin Antibody Product

Table 109. Aladdin Recent Developments/Updates

Table 110. TIANGEN Biotech Company Information

Table 111. TIANGEN Biotech Description and Business Overview

Table 112. TIANGEN Biotech Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. TIANGEN Biotech Beta Actin Antibody Product

Table 114. TIANGEN Biotech Recent Developments/Updates

Table 115. Amyjet Scientific Company Information

Table 116. Amyjet Scientific Description and Business Overview

Table 117. Amyjet Scientific Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Amyjet Scientific Beta Actin Antibody Product

Table 119. Amyjet Scientific Recent Developments/Updates

Table 120. Vazyme Biotech Company Information

Table 121. Vazyme Biotech Description and Business Overview

Table 122. Vazyme Biotech Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Vazyme Biotech Beta Actin Antibody Product

Table 124. Vazyme Biotech Recent Developments/Updates

Table 125. Bioer Technology Company Information

Table 126. Bioer Technology Description and Business Overview

Table 127. Bioer Technology Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Bioer Technology Beta Actin Antibody Product

Table 129. Bioer Technology Recent Developments/Updates

Table 130. Yeasen Company Information

Table 131. Yeasen Description and Business Overview

Table 132. Yeasen Beta Actin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Yeasen Beta Actin Antibody Product

Table 134. Yeasen Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Beta Actin Antibody Distributors List

Table 138. Beta Actin Antibody Customers List

Table 139. Beta Actin Antibody Market Trends

Table 140. Beta Actin Antibody Market Drivers

Table 141. Beta Actin Antibody Market Challenges

Table 142. Beta Actin Antibody Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Beta Actin Antibody

Figure 2. Global Beta Actin Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Beta Actin Antibody Market Share by Type: 2024 & 2031

Figure 4. 2KU Product Picture

Figure 5. 10KU Product Picture

Figure 6. 20KU Product Picture

Figure 7. 100KU Product Picture

Figure 8. Others Product Picture

Figure 9. Global Beta Actin Antibody Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Beta Actin Antibody Market Share by Application: 2024 & 2031

Figure 11. Biopharmaceutical Laboratories

Figure 12. University Laboratories

Figure 13. Others

Figure 14. Global Beta Actin Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Beta Actin Antibody Market Size (2020-2031) & (US$ Million)

Figure 16. Global Beta Actin Antibody Sales (2020-2031) & (K Units)

Figure 17. Global Beta Actin Antibody Average Price (US$/Unit) & (2020-2031)

Figure 18. Beta Actin Antibody Report Years Considered

Figure 19. Beta Actin Antibody Sales Share by Manufacturers in 2024

Figure 20. Global Beta Actin Antibody Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Beta Actin Antibody Players: Market Share by Revenue in Beta Actin Antibody in 2024

Figure 22. Beta Actin Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Beta Actin Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Beta Actin Antibody Sales Market Share by Country (2020-2031)

Figure 25. North America Beta Actin Antibody Revenue Market Share by Country (2020-2031)

Figure 26. United States Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Beta Actin Antibody Sales Market Share by Country (2020-2031)

Figure 29. Europe Beta Actin Antibody Revenue Market Share by Country (2020-2031)

Figure 30. Germany Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Beta Actin Antibody Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Beta Actin Antibody Revenue Market Share by Region (2020-2031)

Figure 37. China Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. China Taiwan Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Beta Actin Antibody Sales Market Share by Country (2020-2031)

Figure 45. Latin America Beta Actin Antibody Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Colombia Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Beta Actin Antibody Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Beta Actin Antibody Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Beta Actin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Beta Actin Antibody by Type (2020-2031)

Figure 56. Global Revenue Market Share of Beta Actin Antibody by Type (2020-2031)

Figure 57. Global Beta Actin Antibody Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Beta Actin Antibody by Application (2020-2031)

Figure 59. Global Revenue Market Share of Beta Actin Antibody by Application (2020-2031)

Figure 60. Global Beta Actin Antibody Price (US$/Unit) by Application (2020-2031)

Figure 61. Beta Actin Antibody Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions